Screener
Xenon Pharmaceuticals XENE Prepaid & Other Current
Prepaid & Other Current at other companies
Other financials
Where this comes from
Reported directly by Xenon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.
The source filing: Xenon Pharmaceuticals’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:31 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338244
FAQ
- What is Xenon Pharmaceuticals's prepaid & other current?
- Xenon Pharmaceuticals (XENE) reported prepaid & other current of $13.55M in Q2 2026.
- How has Xenon Pharmaceuticals's prepaid & other current changed year-over-year?
- Xenon Pharmaceuticals's prepaid & other current increased by 16.7% year-over-year, from $11.61M to $13.55M.
- What is the long-term trend for Xenon Pharmaceuticals's prepaid & other current?
- Over 5 years (2020 to 2025), Xenon Pharmaceuticals's prepaid & other current has grown at a 28.5% compound annual growth rate (CAGR), from $2.96M to $10.39M.
- What does prepaid & other current mean?
- Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.
Ask your AI about Xenon Pharmaceuticals's prepaid & other current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude